Elast-Eon was designed at the Commonwealth Scientific and Industrial Research Organization (CSIRO) in Melbourne, Australia, as a biostable material for use in life-critical medical devices such cardiovascular implants.
Scottish-based AorTech said on Friday they were preparing to begin clinical trials of their "next generation" Elast-Eon implants following a recent meeting with the U.S. Food and Drug Administration.